Traws Pharma Inc Stock Ownership - Who owns Traws Pharma?

Insider buying vs selling

Have Traws Pharma Inc insiders been buying or selling?
Mark Patrick GuerinCFO2024-06-182,221$0.47
Mark Patrick GuerinCFO AND COO2024-03-142,591$0.90
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2024-03-148,727$0.90
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2024-02-079,212$0.67
Mark Patrick GuerinCFO AND COO2024-02-072,443$0.67
Mark Patrick GuerinCFO AND COO2023-08-031,422$1.02
Steven M. FruchtmanPRESIDENT CHIEF EXECUTIVE OFF2023-08-034,744$1.01

1 of 1

TRAW insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRAW insiders and whales buy or sell their stock.

TRAW Shareholders

What type of owners hold Traws Pharma Inc stock?
Michael B. Hoffman27.32%6,911,786$2.90MInsider
Jane Hoffman 2013 Descendants Michael17.86%4,518,275$1.90MInsider
Nikolay Savchuk10.53%2,664,819$1.12MInsider
Gmbh Baxalta10.29%2,603,295$1.09MInsider
Iain D. Dukes7.03%1,779,287$747.30kInsider
Armistice Capital LLC6.54%1,653,902$694.64kInsider
Viriom Inc6.50%1,645,100$690.94kInsider
Tpav LLC4.83%1,222,738$513.55kInsider
Orbimed Advisors LLC4.13%1,045,261$439.01kInsider
Vanguard Group Inc2.80%708,618$297.62kInstitution

1 of 3

TRAW vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRAW6.10%93.90%Net SellingNet Selling
BRTX0.38%99.62%Net Buying
DOMH6.82%93.18%Net BuyingNet Buying
ERNA0.43%99.57%Net SellingNet Selling

Traws Pharma Stock Ownership FAQ

Who owns Traws Pharma?

Traws Pharma (NASDAQ: TRAW) is owned by 6.77% institutional shareholders, 104.33% Traws Pharma insiders, and 0.00% retail investors. Michael B. Hoffman is the largest individual Traws Pharma shareholder, owning 6.91M shares representing 27.32% of the company. Michael B. Hoffman's Traws Pharma shares are currently valued at $3.10M.

If you're new to stock investing, here's how to buy Traws Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.